HomeSLS • NASDAQ
add
Sellas Life Sciences Group Inc
Previous close
$1.52
Day range
$1.42 - $1.55
Year range
$0.50 - $1.91
Market cap
82.15M USD
Avg Volume
1.83M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.18M | -13.43% |
Net income | -8.14M | 10.80% |
Net profit margin | — | — |
Earnings per share | -0.25 | 41.86% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.53M | -85.23% |
Total assets | 6.22M | -70.31% |
Total liabilities | 14.20M | -11.79% |
Total equity | -7.98M | — |
Shares outstanding | 56.27M | — |
Price to book | -6.08 | — |
Return on assets | -285.81% | — |
Return on capital | 398.76% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.14M | 10.80% |
Cash from operations | -4.82M | 6.35% |
Cash from investing | 0.00 | — |
Cash from financing | 3.39M | 264.48% |
Net change in cash | -1.44M | 65.92% |
Free cash flow | -2.71M | -11.54% |
About
Founded
2006
Website
Employees
16